14th July — 12:00 UTC (check local time)
Research Associate at the Motor, Neuron Disease and Neurotrophic Lab, Flinders Health & Medical Research Institute, College of Medicine & Public Health, Flinders University, South Australia. Speaking from Adelaide, Australia.
p75 neurotrophin receptor as a biomarker for ALS clinical trials
Treatment development in Amyotrophic Lateral Sclerosis, a fatal neurodegenerative disease with an average life expectancy of 3-5 years, is hindered by the lack of objective biomarkers. In a world first, we have developed neurotrophin receptor p75ECD as a biomarker of disease progression.